Scientific Publications

SorLA restricts TNFα release from microglia to shape a glioma-supportive brain microenvironment

P. Kaminska
P.L. Ovesen
M. Jakiel
T. Obrebski
V. Schmidt
M. Draminski
A.G. Bilska
M. Bieniek
J. Anink
B. Paterczyk
A.M.G. Jensen
S. Piatek
O.M. Andersen
E. Aronica
T.E. Willnow
B. Kaminska
M.J. Dabrowski
A.R. Malik

Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry

A. Ben Hamza
C. Welters
S. Stadler
M. Brüggemann
K. Dietze
O. Brauns
T.H. Brümmendorf
T.H. Winkler
L. Bullinger
T. Blankenstein
L. Rosenberger
M. Leisegang
T. Kammertöns
W. Herr
A. Moosmann
J. Strobel
H. Hackstein
K. Dornmair
F. Beier
L. Hansmann

HLA-C*04:09N is expressed at the cell surface and triggers peptide-specific T-cell activation

C. Welters
M.L. Welters
S. Stadler
L. Bullinger
J. Strobel
H. Hackstein
A. Dhamodaran
T. Blankenstein
L. Hansmann

Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al

L. Immisch
G. Papafotiou
O. Popp
P. Mertins
T. Blankenstein
G. Willimsky

IFNγ binding to extracellular matrix prevents fatal systemic toxicity

J. Kemna
E. Gout
L. Daniau
J. Lao
K. Weißert
S. Ammann
R. Kühn
M. Richter
C. Molenda
A. Sporbert
D. Zocholl
R. Klopfleisch
A. Schütz
H. Lortat-Jacob
P. Aichele
T. Kammertoens
T. Blankenstein

Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors

L. Immisch
G. Papafotiou
N. Gallarín Delgado
V. Scheuplein
A. Paschen
T. Blankenstein
G. Willimsky

Generation of TGFβR2(-1) neoantigen-specific HLA-DR4-restricted T cell receptors for cancer therapy

N. Plewa
L. Poncette
T. Blankenstein

November 01, 2022 / Cancer Immunol Res

Immune phenotypes and target antigens of clonally expanded bone marrow T cells in treatment-naïve multiple myeloma

C. Welters
M.F. Lammoglia Cobo
C.A. Stein
M.T. Hsu
A. Ben Hamza
L. Penter
X. Chen
C. Buccitelli
O. Popp
P. Mertins
K. Dietze
L. Bullinger
A. Moosmann
E. Blanc
D. Beule
A. Gerbitz
J. Strobel
H. Hackstein
H.P. Rahn
K. Dornmair
T. Blankenstein
L. Hansmann

H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2(+) patients with diffuse midline glioma

L. Immisch
G. Papafotiou
O. Popp
P. Mertins
T. Blankenstein
G. Willimsky

Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapy

M.F. Lammoglia Cobo
C. Welters
L. Rosenberger
M. Leisegang
K. Dietze
C. Pircher
L. Penter
R. Gary
L. Bullinger
A. Takvorian
A. Moosmann
K. Dornmair
T. Blankenstein
T. Kammertöns
A. Gerbitz
L. Hansmann